MyMD Pharmaceuticals effectuates 1-for-30 reverse stock split to maintain Nasdaq listing

Q/C TECHNOLOGIES, INC.

Reverse stock split at 1-for-30 ratio effective Feb 14, 2024 at 4:05 p.m. EST.
Outstanding shares reduced from ~62.7M to ~2.09M; authorized shares reduced from 500M to 16.67M.
Common stock begins trading on split-adjusted basis Feb 15 under same ticker MYMD; new CUSIP 62856X201.
Fractional shares rounded up to nearest whole share; proportional adjustments to warrants, preferred stock, and equity awards.
Company states split is intended to maintain compliance with Nasdaq listing requirements.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Q/C TECHNOLOGIES, INC.: Certificate of Amendment filed to effect a 1-for-30 reverse stock split and reduce authorized shares from 500 million to 16,666,666 (effective 2024-02-14).

Change: charter amendment
Effective: 2024-02-14

Exact text from the filing

On February 13, 2024, MyMD Pharmaceuticals, Inc. (the " Company ") announced that it had filed with the Secretary of State of the State of New Jersey a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation (the " Charter Amendment ") to effect a 1-for-30 reverse stock split (the " Reverse Stock Split ") of the Company’s common stock, without par value (the " Common Stock "), effective as of 4:05 p.m. Eastern Standard Time on February 14, 2024 (the " Effective Time ").

View on SEC.gov

247 governance changes filed in the last 30 days. Browse all governance changes →

Q/C TECHNOLOGIES, INC. filing history →

Source: SEC EDGAR

accession 0001493152-24-006163

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.